Levnibiot

Levofloxacin, the active ingredient in Levnibiot, is a fluoroquinolone presented as an oral tablet for oral use. It is employed to treat a range of bacterial infections, including respiratory, urinary, and skin infections, in adult patients where such therapy is indicated.

GNH USA supplies Levnibiot as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, with established quality‑assurance processes and regulatory approvals across European and Asian markets for your needs.

Levofloxacin is a broad‑spectrum fluoroquinolone antibiotic used to treat bacterial infections in several organ systems. - Community‑acquired respiratory tract infection: reduces bacterial load and improves symptoms such as cough and fever. - Urinary tract infection: eradicates susceptible uropathogens and resolves dysuria and urgency. - Skin and soft tissue infection: eliminates causative bacteria, promoting healing of cellulitis and abscesses. - Acute bacterial sinusitis: clears sinus inflammation caused by susceptible organisms, relieving congestion and facial pain. - Acute bacterial pharyngitis: treats streptococcal and other bacterial throat infections, alleviating sore throat and fever.

Levofloxacin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness or imbalance.

Serious or Rare Side Effects: - Tendon rupture: sudden pain or swelling, especially in the Achilles tendon. - QT interval prolongation: cardiac rhythm changes that may lead to arrhythmia. - Severe hypersensitivity: rash, Stevens‑Johnson syndrome, or anaphylaxis.

Before prescribing Levofloxacin, clinicians should evaluate patient risk factors and follow safety guidelines. - Assess renal function: dose adjustment may be required in impaired clearance. - Review history of tendon disorders: avoid in patients with recent tendon injury or corticosteroid use. - Monitor cardiac status: caution in individuals with known QT prolongation or electrolyte disturbances. - Avoid use in pregnancy and lactation unless benefits outweigh risks, due to unknown safety data. - Counsel patients on photosensitivity: advise protection from excessive sunlight. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture.

Levofloxacin interacts with several medicines; awareness of major and moderate interactions helps prevent adverse events.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption; separate dosing by at least 2 hours. - Warfarin: may increase INR and bleeding risk; monitor coagulation parameters closely. - Theophylline: elevated plasma levels can cause toxicity; consider dose reduction.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of central nervous system stimulation. - Diabetic agents (e.g., insulin, sulfonylureas): levofloxacin can enhance hypoglycemia; monitor blood glucose. - Corticosteroids: combined use may raise tendon rupture risk; advise patient vigilance.